| Date Filed | Type | Description |
| 06/16/2023 |
4
| Bazemore Robert B (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 49,237 options to buy
@ $3.92, valued at
$193k
|
|
| 05/17/2023 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 06/28/2022 |
4/A
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 140,713 options to buy
@ $4.05, valued at
$569.9k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 118,784 options to buy
@ $4.05, valued at
$481.1k
|
|
| 11/02/2021 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 45,229 options to buy
@ $9.17, valued at
$414.7k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Bought 5,000 shares
@ $9.9799, valued at
$49.9k
|
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 51,703 options to buy
@ $4.6, valued at
$237.8k
Granted 187,658 options to buy
@ $1.74, valued at
$326.5k
|
|
| 02/12/2021 |
3
| Bazemore Robert B (Director) has filed a Form 3 on Nuvation Bio Inc. |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 6,069 shares
@ $11.41, valued at
$69.2k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Bazemore Robert B (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 23,500 options to buy
@ $7.31, valued at
$171.8k
|
|
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2020 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed of 56,537 shares
@ $0
Granted 113,393 shares
@ $0
Granted 7,000 shares
@ $0
Sold 3,285 shares
@ $15.28, valued at
$50.2k
Disposed of 79,167 options to buy
@ $8.98, valued at
$710.9k
Disposed of 2,371 options to buy
@ $12.45, valued at
$29.5k
Disposed of 48,727 options to buy
@ $9.12, valued at
$444.4k
Granted 73,409 options to buy
@ $16.14, valued at
$1.2M
|
|
| 02/05/2020 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 52,595 shares
@ $0
Granted 252,956 options to buy
@ $21.39, valued at
$5.4M
|
|
| 01/27/2020 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,750 shares
@ $0
Sold 3,002 shares
@ $24.62, valued at
$73.9k
Sold 6,074 shares
@ $20.44, valued at
$124.2k
|
|
| 06/27/2019 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 06/17/2019 |
4
| Bazemore Robert B (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.74, valued at
$137k
|
|
| 06/14/2019 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 7,000 shares
@ $0
Sold 2,074 shares
@ $12.1, valued at
$25.1k
|
|
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2018 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 28,000 options to buy
@ $7.56, valued at
$211.7k
|
|
| 11/07/2018 |
3
| Bazemore Robert B (Director) has filed a Form 3 on Neon Therapeutics, Inc. |
| 06/15/2018 |
4
| Bazemore Robert B (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 15,000 options to buy
@ $4.03, valued at
$60.5k
|
|
| 02/13/2018 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 265,860 options to buy
@ $16, valued at
$4.3M
|
|
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 1,708 shares
@ $6.2135, valued at
$10.6k
|
|
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Bazemore Robert B (President & CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 1,362 shares
@ $6.2135, valued at
$8.5k
|
|
| 06/06/2016 |
4
| Bazemore Robert B (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 25,000 options to buy
@ $9.27, valued at
$231.8k
|
|